News
On the eve of Earth Day 2025, researchers from Bar-Ilan University and the Volcani Center are advancing new, environmentally ...
New research suggests that lingering cell wall fragments from the Lyme disease bacterium, Borrelia burgdorferi, may be responsible for persistent symptoms long after antibiotic treatment.
A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...
As Earth Day is marked on April 22, Israeli researchers are advancing a promising eco-friendly alternative to traditional ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...
Cultivarium, a non-profit bioengineering firm, announced today a three-year project to develop advanced tools for life scientists studying fungi and archaea. With USD $10 million in funding from ...
A new study has identified a potential new therapy for pulmonary tuberculosis that could shorten the length of treatment and ...
3d
News-Medical.Net on MSNExperimental cancer drug shows promise in boosting tuberculosis treatmentAn experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...
Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...
Ankur Mutreja, Tikesh Bisen, and Balaji Veeraraghavan address the urgent global health challenge of antimicrobial resistance.
As China's first space experiment involving planarians, the Shenzhou-20 mission will study the effects of space on planarian regeneration using head, middle and tail segments, with potential ...
Tribal Agriculture Fellowship announced its 2025 cohort on Friday. TAF is committed to empowering Native American students ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results